NCT02511990 A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074 Status COMPLETED Phase PHASE1
NCT02509195 SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over Status COMPLETED Phase PHASE4
NCT02503618 Understanding Substance Use and Incident HIV/STI Among Young Black MSM Status COMPLETED Phase N/A
NCT02503072 Rewarding Adherence Program - an Intervention Using Small Prizes Allocated by a Prize Drawing to Increase ARV Adherence Status COMPLETED Phase NA
NCT02500849 Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02499874 SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women Status COMPLETED Phase PHASE1
NCT02497456 The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda Status COMPLETED Phase NA
NCT02493647 Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk Status COMPLETED Phase NA
NCT02492893 Yoga Intervention for Substance Use and ART Adherence in Community Reentry Status COMPLETED Phase NA
NCT02487706 Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease Status COMPLETED Phase PHASE4
NCT02483078 Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140 Status COMPLETED Phase PHASE2/PHASE3
NCT02479659 Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services Status COMPLETED Phase NA
NCT02477527 Atripla to Stribild Switch Study to Evaluate Sleep Disturbances Status COMPLETED Phase PHASE4
NCT02475629 Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Status COMPLETED Phase PHASE3
NCT02474992 The Kanyakla Study: a Microclinic Social Network Intervention for Promoting Engagement and Retention in HIV Care Status COMPLETED Phase NA
NCT02471326 VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption Status COMPLETED Phase PHASE1